公开(公告)号：US20100047271A1

公开(公告)日：2010-02-25

申请号：US12612992

申请日：2009-11-05

申请人： Debbi Drane ,  John Cox ,  Michael Houghton ,  Xavier Pallard

发明人： Debbi Drane ,  John Cox ,  Michael Houghton ,  Xavier Pallard

IPC分类号： A61K39/29 ,  A61P31/12

CPC分类号： A61K39/29 ,  A61K39/12 ,  A61K2039/55544 ,  A61K2039/55566 ,  A61K2039/55572 ,  A61K2039/55577 ,  A61K2039/57 ,  C12N2770/24234

摘要： The present invention relates generally to an immunogenic complex comprising a charged organic carrier and a charged antigen and, more particularly, a negatively charged organic carrier and a positively charged antigen, wherein the charged antigen is a polyprotein of Hepatitis C Virus (HCV), particularly the core protein of HCV, or a fragment thereof, or a fusion protein comprising the polyprotein or a fragment thereof. The complexes of the present invention are useful, inter alia, in vaccine compositions as therapeutic and/or prophylactic agents for facilitating the induction of immune responses, and in particular a cytotoxic T-lymphocyte response, in the treatment of a disease condition which results from an HCV infection.

摘要翻译： 本发明一般涉及包含带电荷的有机载体和带​​电荷的抗原的免疫原性复合物，更具体地，涉及带负电荷的有机载体和带​​正电荷的抗原，其中带电的抗原是丙型肝炎病毒（HCV）的多蛋白，特别是 HCV的核心蛋白或其片段，或包含该多聚蛋白或其片段的融合蛋白。 本发明的复合物尤其可用于疫苗组合物中，作为促进免疫应答诱导的治疗和/或预防剂，特别是细胞毒性T淋巴细胞应答，用于治疗由 HCV感染。